StockData
DarioHealth Corp. logo

DarioHealth Corp. (DRIO) stock

DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.46+0.31 (+26.96%)

Close on Nov 18, 2026Market cap $14.31MP/E 0.4Yield –

Earnings

DarioHealth's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2022
$6.70M
EPS, Q4 FY2022
–
Latest guidance
Issued
Jan 19, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of DarioHealth's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2023ended Jun 30, 2023Jul 24, 2023before the open–––Release
Q4 FY2022ended Dec 31, 2022Feb 6, 2023before the open$6.70M––Release
Q2 FY2022ended Jun 30, 2022Aug 15, 2022before the open$6.20M–$0.74Release
Q4 FY2021ended Dec 31, 2021Jan 19, 2022before the open–––Release
Q2 FY2021ended Jun 30, 2021Aug 16, 2021before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period DarioHealth guided for has been reported

Guidance history

Every forecast DarioHealth put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Jan 19, 2022revenuesFY2021$20.30M – $20.50MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases DarioHealth filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. News
  5. News
  6. News
  7. Update
  8. Update
  9. Update
  10. Update
  11. Results
  12. News
  13. News
  14. Results
  15. Results

See a number that looks wrong?